Wild Child Netted Down Under In US FDA Initiative To Inspect All Drug Facilities

FDA says Wild Child, which provides products as a contract manufacturer and for private label sales, violated drug GMPs for products including sun care, lice treatment and acne lotion and attempted to avoid US testing standards by relying on Australian mandates.

Australia on atlas world map

More from Regulation

More from Policy & Regulation